Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-006612
Filing Date
2025-05-07
Accepted
2025-05-07 07:45:34
Documents
62
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cgtx-20250331x10q.htm   iXBRL 10-Q 1120478
2 EX-31.1 cgtx-20250331xex31d1.htm EX-31.1 16604
3 EX-31.2 cgtx-20250331xex31d2.htm EX-31.2 16893
4 EX-32.1 cgtx-20250331xex32d1.htm EX-32.1 9959
5 EX-32.2 cgtx-20250331xex32d2.htm EX-32.2 9947
  Complete submission text file 0001558370-25-006612.txt   5151693

Data Files

Seq Description Document Type Size
6 EX-101.SCH cgtx-20250331.xsd EX-101.SCH 37235
7 EX-101.CAL cgtx-20250331_cal.xml EX-101.CAL 39072
8 EX-101.DEF cgtx-20250331_def.xml EX-101.DEF 140736
9 EX-101.LAB cgtx-20250331_lab.xml EX-101.LAB 346528
10 EX-101.PRE cgtx-20250331_pre.xml EX-101.PRE 261166
65 EXTRACTED XBRL INSTANCE DOCUMENT cgtx-20250331x10q_htm.xml XML 732822
Mailing Address 2500 WESTCHESTER AVE PURCHASE NY 10577
Business Address 2403 SIDNEY STREET SUITE 261 PITTSBURGH PA 15203 412-481-2210
COGNITION THERAPEUTICS INC (Filer) CIK: 0001455365 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40886 | Film No.: 25919342
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)